Nick Manamley
Nick Manamley publishes mostly in Molecular Biology, Infectious Diseases and Hematology, on topics such as Erythropoietin and Anemia Treatment, Antifungal resistance and susceptibility and Histone Deacetylase Inhibitors Research.
- World rank
- #3,835,022 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #247,747 of 367,258
- Works
- 34
- Citations
- 249
- Citations per work
- 7.3
What does Nick Manamley research?
Nick Manamley's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1543.0%
- Health Sciences1133.7%
- Medicine1133.7%
- Life Sciences823.3%
- 1Molecular Biology14% of their works
- 2Infectious Diseases12% of their works
- 3Hematology10% of their works
- 4Immunology9% of their works
- 5Nephrology8% of their works
- 6Epidemiology4% of their works
Research topics
- Erythropoietin and Anemia Treatment
- Antifungal resistance and susceptibility
- Histone Deacetylase Inhibitors Research
- Biosimilars and Bioanalytical Methods
- Parasitic Diseases Research and Treatment
- Aluminum toxicity and tolerance in plants and animals
- Heavy Metal Exposure and Toxicity
- Dialysis and Renal Disease Management
Which keywords describe Nick Manamley's research?
The keywords of their largest research topics: Cardiovascular Disease, Chronic Kidney Disease, Anemia, Candidiasis, Heart Failure, Invasive Fungal Infections, Oxidative Stress and Biosimilars.
- Metal Toxicity
- Inflammation
- Aluminum Toxicity
- Ivermectin
- Histone Deacetylases
- Biosimilars
- Invasive Fungal Infections
- Candidiasis
- Chronic Kidney Disease
- Cardiovascular Disease
- Anemia
- Heart Failure
- Oxidative Stress
- HDAC Inhibitors
- Immunogenicity
- Lymphatic Filariasis
- Dialysis
- Lead Exposure
- Plant Adaptation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cardiovascular Disease92 topics
- Chronic Kidney Disease92 topics
- Anemia61 topic
- Candidiasis61 topic
- Heart Failure61 topic
- Invasive Fungal Infections61 topic
- Oxidative Stress62 topics
- Biosimilars51 topic
- HDAC Inhibitors51 topic
- Histone Deacetylases51 topic
- Immunogenicity51 topic
- Ivermectin41 topic
- Lymphatic Filariasis41 topic
- Aluminum Toxicity31 topic
- Dialysis31 topic
- Inflammation31 topic
- Lead Exposure31 topic
- Metal Toxicity31 topic
- Plant Adaptation31 topic
Where does Nick Manamley work?
Nick Manamley's main affiliation in the publication record is Mundipharma (United Kingdom), United Kingdom.
How many publications and citations does Nick Manamley have?
OpenAlex counts 34 works and 249 citations for Nick Manamley, an h-index of 9, ranking #3,835,022 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nick Manamley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.